mefenamic acid has been researched along with B16 Melanoma in 1 studies
Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, K | 1 |
| Takahashi, H | 1 |
| Toriyama, M | 1 |
1 other study available for mefenamic acid and B16 Melanoma
| Article | Year |
|---|---|
Depigmenting mechanism of NSAIDs on B16F1 melanoma cells.
Topics: alpha-MSH; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Intramolecular Oxid | 2011 |